A high-throughput, 28-day, microfluidic model of gingival tissue inflammation and recovery.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
23 01 2023
Historique:
received: 11 06 2021
accepted: 05 01 2023
entrez: 23 1 2023
pubmed: 24 1 2023
medline: 26 1 2023
Statut: epublish

Résumé

Nearly half of American adults suffer from gum disease, including mild inflammation of gingival tissue, known as gingivitis. Currently, advances in therapeutic treatments are hampered by a lack of mechanistic understanding of disease progression in physiologically relevant vascularized tissues. To address this, we present a high-throughput microfluidic organ-on-chip model of human gingival tissue containing keratinocytes, fibroblast and endothelial cells. We show the triculture model exhibits physiological tissue structure, mucosal barrier formation, and protein biomarker expression and secretion over several weeks. Through inflammatory cytokine administration, we demonstrate the induction of inflammation measured by changes in barrier function and cytokine secretion. These states of inflammation are induced at various time points within a stable culture window, providing a robust platform for evaluation of therapeutic agents. These data reveal that the administration of specific small molecule inhibitors mitigates the inflammatory response and enables tissue recovery, providing an opportunity for identification of new therapeutic targets for gum disease with the potential to facilitate relevant preclinical drug efficacy and toxicity testing.

Identifiants

pubmed: 36690695
doi: 10.1038/s42003-023-04434-9
pii: 10.1038/s42003-023-04434-9
pmc: PMC9870913
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

92

Informations de copyright

© 2023. The Author(s).

Références

Lab Chip. 2020 Oct 7;20(19):3653
pubmed: 32756648
Lab Chip. 2013 Jun 21;13(12):2311-9
pubmed: 23636129
Invest Clin. 2016 Jun;57(2):131-142
pubmed: 28429894
Clin Exp Immunol. 2002 Jun;128(3):548-54
pubmed: 12067311
Contemp Clin Dent. 2013 Jul;4(3):303-6
pubmed: 24124294
Sci Rep. 2016 Mar 15;6:23060
pubmed: 26976446
Adv Healthc Mater. 2018 Jan;7(2):
pubmed: 29205920
Mol Cell Biol. 2019 Jun 27;39(14):
pubmed: 31061092
Front Oral Health. 2022 Jan 05;2:815728
pubmed: 35048079
Acta Ophthalmol. 2013 Dec;91(8):744-50
pubmed: 22963401
Am J Physiol Cell Physiol. 2001 Sep;281(3):C1038-45
pubmed: 11502582
J Tissue Eng Regen Med. 2018 Feb;12(2):e1088-e1097
pubmed: 28388010
Cent Eur J Immunol. 2018;43(1):76-80
pubmed: 29736149
Periodontol 2000. 2004;34:9-21
pubmed: 14717852
Virulence. 2015;6(3):265-73
pubmed: 25587671
J Clin Periodontol. 2003 Dec;30(12):1046-52
pubmed: 15002890
Tissue Eng Regen Med. 2016 Aug 5;13(4):428-436
pubmed: 30603424
J Dent Res. 2012 Oct;91(10):914-20
pubmed: 22935673
Biomicrofluidics. 2018 Sep 26;12(5):054106
pubmed: 30310527
PLoS One. 2021 Jan 8;16(1):e0244806
pubmed: 33417619
J Periodontol. 2012 Mar;83(3):362-8
pubmed: 21859321
J Dent (Tehran). 2013 Jan;10(1):1-9
pubmed: 23724197
Sci Rep. 2018 Oct 30;8(1):16061
pubmed: 30375445
Adv Healthc Mater. 2018 Jan;7(2):
pubmed: 28945001
Adv Healthc Mater. 2018 Jul;7(14):
pubmed: 30134074
Nat Biomed Eng. 2020 Apr;4(4):421-436
pubmed: 31988459
Tissue Eng Part C Methods. 2018 Feb;24(2):99-107
pubmed: 29092692
Cells. 2014 May 23;3(2):476-99
pubmed: 24861975
J Clin Periodontol. 2016 Sep;43(9):727-45
pubmed: 27027257
Sci Rep. 2018 Mar 14;8(1):4530
pubmed: 29540740
Eur J Immunol. 1995 Oct;25(10):2888-93
pubmed: 7589088
Integr Biol (Camb). 2015 Apr;7(4):383-91
pubmed: 25739725
PLoS One. 2017 Oct 11;12(10):e0184330
pubmed: 29020011
J Signal Transduct. 2012;2012:308943
pubmed: 22315682
Respir Res. 2007 Oct 04;8:71
pubmed: 17916230
Lancet. 2012 Mar 10;379(9819):943-952
pubmed: 22405797
Lab Chip. 2017 Jun 27;17(13):2264-2271
pubmed: 28598479
J Periodontol. 2001 Apr;72(4):461-9
pubmed: 11338298
Lab Chip. 2016 Dec 20;17(1):134-144
pubmed: 27901159
Integr Biol (Camb). 2012 Jan;4(1):75-83
pubmed: 22139064
Lab Chip. 2021 Apr 20;21(8):1454-1474
pubmed: 33881130
Pulm Circ. 2014 Dec;4(4):535-51
pubmed: 25610592
J Periodontol. 2006 May;77(5):856-64
pubmed: 16671879
J Clin Periodontol. 2010 Apr;37(4):324-33
pubmed: 20447255
Tissue Barriers. 2018;6(3):1479568
pubmed: 30252599
J Lab Autom. 2015 Apr;20(2):107-26
pubmed: 25586998
Cytotherapy. 2014 Sep;16(9):1171-86
pubmed: 24934304
ALTEX. 2020 Feb 28;37(3):365-394
pubmed: 32113184
J Evid Based Dent Pract. 2018 Dec;18(4):315-331
pubmed: 30514445
J R Soc Interface. 2012 Dec 7;9(77):3528-38
pubmed: 22915635
Int J Chronic Dis. 2014;2014:363581
pubmed: 26464855
Lab Chip. 2017 Sep 12;17(18):3026-3036
pubmed: 28795174
PLoS One. 2016 Feb 29;11(2):e0149550
pubmed: 26926476
Nat Commun. 2017 Mar 28;8:14584
pubmed: 28350383
J Clin Diagn Res. 2014 Nov;8(11):ZC75-9
pubmed: 25584323
Biotechnol Bioeng. 2019 Dec;116(12):3409-3420
pubmed: 30963546
Med Immunol. 2006 Aug 14;5:3
pubmed: 16907989
Tissue Eng Part C Methods. 2016 Aug;22(8):781-91
pubmed: 27406216
J Periodontol. 2000 Oct;71(10):1535-45
pubmed: 11063385
Am J Pathol. 2011 Apr;178(4):1676-88
pubmed: 21435451
J Cell Sci. 2002 May 15;115(Pt 10):2219-32
pubmed: 11973362
Curr Drug Metab. 2009 Jan;10(1):55-67
pubmed: 19149513
Science. 2010 Jun 25;328(5986):1662-8
pubmed: 20576885
Bull Tokyo Dent Coll. 2019 Dec 10;60(4):279-289
pubmed: 31761881
Front Oral Health. 2021 Jul 14;2:689475
pubmed: 35048035
An Bras Dermatol. 2021 Mar-Apr;96(2):163-170
pubmed: 33531183

Auteurs

Ashley L Gard (AL)

Bioengineering Division, Draper, Cambridge, MA, USA.

Rebeccah J Luu (RJ)

Bioengineering Division, Draper, Cambridge, MA, USA.

Ryan Maloney (R)

Bioengineering Division, Draper, Cambridge, MA, USA.

Madeline H Cooper (MH)

Bioengineering Division, Draper, Cambridge, MA, USA.

Brian P Cain (BP)

Bioengineering Division, Draper, Cambridge, MA, USA.

Hesham Azizgolshani (H)

Bioengineering Division, Draper, Cambridge, MA, USA.

Brett C Isenberg (BC)

Bioengineering Division, Draper, Cambridge, MA, USA.

Jeffrey T Borenstein (JT)

Bioengineering Division, Draper, Cambridge, MA, USA.

Jane Ong (J)

Colgate-Palmolive Company, Piscataway, NJ, USA.

Joseph L Charest (JL)

Bioengineering Division, Draper, Cambridge, MA, USA.

Else M Vedula (EM)

Bioengineering Division, Draper, Cambridge, MA, USA. evedula@draper.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH